TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive OMB Proposal Would Slash NIH Budget $500 Million, NCI’s Reduction Could Be As Much As $125 Million January 3, 1986
